The Nelson Report

By integrating Anthropic's Model Context Protocol, Orion is transforming its open API architecture into a secure, agentic AI engine for financial advisors.

Los Angeles Cancer Network's rebrand to Oncura Health signals a massive shift in Southern California, leveraging private capital to decentralize cancer care.

As 'pinkwashing' scrutiny grows, G-SHOCK’s flat-fee philanthropy and strategic use of the 'CasiOak' silhouette offer a blueprint for authentic corporate giving.

Armed with $33 million in Series B funding, the microbiome data platform is building a B2B clinical infrastructure to power precision medicine.

Ascribe Bioscience has secured the world’s first regulatory approval for an ascaroside biofungicide. Here is why the Cornell spinout bypassed the US for Brazil.

As 90% of tested brands show links to prohibited cotton, Oritain's new 7-day forensic testing and API integration turns compliance into a competitive edge.

As AI infrastructure costs strain law firms and CFOs turn disputes into balance-sheet assets, legal finance is quietly reshaping corporate strategy.

Generative AI is failing to deliver enterprise ROI. The culprit isn't the software—it's a lack of operational leadership and the rise of 'workslop'.

Assertive Professionals has secured a pivotal $14.7M contract to streamline DCSA's acquisition operations, signaling a strategic shift in defense procurement.

A new survey reveals the hidden exhaustion of video marketing, driving trust-based professionals and female entrepreneurs toward synthetic digital clones.

Vuzix is pivoting to a value-added distribution model in Australia and New Zealand, targeting remote industrial sectors with AI-powered smart glasses.

Brian Nelson analyzes how a 90-year-old British kitchen brand is leveraging operational innovation to disrupt the high-margin home climate control market.

Minerva University just secured the No. 1 spot in U.S. News. Brian Nelson unpacks the asset-light operational model disrupting traditional higher education.

By leveraging deuterated chemistry, Aviva Bio aims to bypass the oncologic risks that have stalled FDA approval for female testosterone therapies for decades.

A new initiative offers free blockchain voting to HOAs, blending cryptographic proof with a shrewd freemium model to capture a massive, fragmented market.

With over $100M in new capital, Delos Data unveils an architecture for the always-on demands of agentic AI, tackling the critical network bottleneck.

New research reveals employees save hours with AI but fear being fired for its mistakes, creating a high-stakes environment of reckless use and hidden risks.

After 50x revenue growth in stealth, Fin.com emerges with $20M and a radical playbook: acquiring local operators to fix broken cross-border payments.

Axe Compute sells its Helomics cancer lab, completing its pivot to a pure-play AI infrastructure provider and betting its future on the GPU gold rush.

Beacon's new ETF aims to tame alternatives with a novel, granular risk-control system, making assets from gold to crypto more accessible for portfolios.